Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial ResultsBusiness Wire • 03/02/26
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care ConferenceBusiness Wire • 02/20/26
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026Business Wire • 02/17/26
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical PracticeBusiness Wire • 01/22/26
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides OutlookBusiness Wire • 01/11/26
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of AmericaBusiness Wire • 12/10/25
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue GuidanceBusiness Wire • 11/06/25
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual MeetingBusiness Wire • 10/21/25
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025Business Wire • 10/16/25
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet TransfusionsBusiness Wire • 08/25/25
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025Business Wire • 08/21/25
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025Business Wire • 07/22/25
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic InjuryBusiness Wire • 07/21/25
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application UpdateBusiness Wire • 07/02/25
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025Business Wire • 06/03/25
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in MilanBusiness Wire • 05/29/25
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination DeviceBusiness Wire • 05/28/25